Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677012 · ClinicalTrials.gov registry record
Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT02677012: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02677012 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02677012 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This randomized clinical trial studies and compares 3 techniques in performing autologous fat grafting (AFG) in patients undergoing surgery to reshape or rebuild (reconstruct) a part of the body changed by previous surgery and inserted into another part of the body. AFG, also called fat injections or fat transplant, is a procedure in which an individual's own body fat (usually from abdomen or legs) is used during reconstructive surgery. Doctors want to compare 3 techniques for processing the fat tissue collected during surgery and the length of time needed to complete each AFG technique and surgery. Comparing 3 AFG techniques and the time to complete them during surgery may help doctors determine the best technique to perform fat grafting in the future.
Primary Outcome
Study data will be collected and managed using the Research Electronic Data Capture. This study will measure and compare the rate of fat processed, defined as the volume of fat processed per unit time associated with the use of three adipose tissue processing techniques.
Interventions
- PROCEDURE Autologous Fat Graft
- PROCEDURE Reconstructive Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-02-04 |
| Est. Completion | 2020-07-03 |
What the finished NCT02677012 record still lists
NCT02677012 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Autologous Fat Graft is the first listed.
NCT02677012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02677012 about?
NCT02677012 is a clinical study titled "Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery". This randomized clinical trial studies and compares 3 techniques in performing autologous fat grafting (AFG) in patients undergoing surgery to reshape or rebuild (reconstruct) a part of the body changed by previous surgery and inserted into another part of the body. AFG, also called fat injections o...
What is the current status of trial NCT02677012?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-02-04. Estimated completion is 2020-07-03.
What interventions are being tested in trial NCT02677012?
The interventions under investigation include: Autologous Fat Graft (PROCEDURE), Reconstructive Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02677012?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI